Skip to main content
The Lancet Regional Health - Southeast Asia logoLink to The Lancet Regional Health - Southeast Asia
. 2023 Dec 6;21:100340. doi: 10.1016/j.lansea.2023.100340

Monitoring and evaluation practices and operational research during public health emergencies in southeast Asia region (2012–2022) – a systematic review

Lubaba Shahrin a,b, Iffat Nowrin c, Sadia Afrin c, Md Zamiur Rahaman d, Md Maksud Al Hasan a, KM Saif-Ur-Rahman e,f,
PMCID: PMC10866922  PMID: 38361592

Summary

This systematic review aimed to explore the monitoring and evaluation (M&E) and operational research (OR) practices during public health emergencies (PHE) in the southeast Asian region (SEAR) over the last decade. We searched electronic databases and grey literature sources for studies published between 2012 and 2022. The studies written in English were included, and a narrative synthesis was undertaken. A total of 29 studies were included in this review. Among these 25 studies documented M&E and four studies documented OR practices. The majority of the studies were from India and Bangladesh, with no evidence found from Sri Lanka, Bhutan, Myanmar, and Timor-Leste. M&E of surveillance programs were identified among which PHE due to COVID-19 was most prevalent. M&E was conducted in response to COVID-19, cholera, Nipah, Ebola, Candida auris, and hepatitis A. OR practice was minimal and reported from India and Indonesia. India conducted OR on COVID-19 and malaria, whereas Indonesia focused on COVID-19 and influenza. While most SEAR countries have mechanisms for conducting M&E, there is a noticeable limitation in OR practices. There is a compelling need to develop a standard framework for M&E. Additionally, enhancing private sector engagement is crucial for strengthening preparedness against PHE. Furthermore, there is a necessity to increase awareness about the importance of conducting M&E and OR during PHE.

Keywords: Monitoring & evaluation, Operational research, Public health emergency, Systematic review, Southeast Asia


Search strategy and selection criteria.

We developed a comprehensive search strategy following the PCC (Population, Content, Context) and using keywords such as ‘SEAR countries’, ‘Operational research’, ‘Monitoring and evaluation’, ‘Assessment’, ‘Emergency preparedness’, ‘Emergency response’, ‘Risk communications’, ‘Outbreak investigation’, ‘Outbreak response’, ‘Risk Management’, ‘Public health emergency’, ‘Outbreak’, ‘Pandemic’, ‘Endemic’ etc. The review has considered both peer-reviewed and grey literature. We have searched the electronic bibliographic databases such as–Medline (through PubMed), the Cochrane Library (Cochrane Central Register of Controlled Trials), Scopus, Web of Science (core collection) and EMBASE; Impact Evaluation Databases, relevant Bilateral Aid Agencies and Health ministries of SEAR countries (see Supplementary File).

Inclusion Criteria

  • All types of quantitative, qualitative, and mixed-method studies were considered

  • All study designs including randomised controlled trials, non-randomised trials or quasi-experimental studies, cross-sectional studies, comparative cross-sectional studies, and observational studies were considered

  • Government reports, policy statements, research reports, opinion papers, editorials, commentary, letters to the editor, etc. were also included

  • Any study was included if it focuses on monitoring and evaluating measures taken to address the public health emergency

  • If the study focuses on monitoring and evaluation of any kind of trial to address public health emergencies, were considered

  • If any study focuses on any operational research conducted during any kind of public health emergencies

  • Considering the above criteria, studies published between Jan 1, 2012 and July 30, 2022 in English were included.

Exclusion criteria

  • The study focuses on the effectiveness of intervention (e.g. trial to find out the efficacy of a drug, vaccine, etc.) rather than monitoring and evaluation of the process

  • The geographical location (countries other than SEAR countries)

  • Year of publication before 2012

  • Language other than English

Background

Around 600 million people live in southeast Asia, where numerous factors promote the emergence of infectious diseases.1 Emerging infections with pandemic potential are anticipated to spread more rapidly than in previous times in southeast Asian region (SEAR).1 Numerous diversities in biological, geographical, and socio-economical characteristics contributed to this region as a hotspot for emerging infectious diseases.2 SEAR is portrayed as the hub for zoonotic and vector-borne diseases that originated elsewhere for population growth, mobility, urbanisation, agriculture and livestock, deforestation, and climate change.3, 4, 5 Among annual global deaths, 40% or 14 million are caused by infectious diseases.6 SEAR's inhabitants are particularly susceptible to neglected tropical diseases (NTDs), including dengue, chikungunya, Japanese encephalitis, influenza, and COVID-19.7

Large-scale outbreaks of diseases such as SARS (2003), H1N1 (2009), Ebola (2014), Zika (2016), and more recently, COVID-19 have demonstrated how PHE influenced negative socio-economic effects in addition to significant morbidity and mortality.8 Emerging infectious diseases have the potential for public health emergencies (PHE) leading to significant influence on community health and well-being, healthcare systems, national economies' stability, and sustainable development goals.3, 4, 5

WHO has created a framework that identifies five essential elements that must be present to build a successful public health response during any kind of PHE: monitoring, healthcare response, public health intervention, communication, and command.9 Monitoring and evaluation (M&E) aim to assess the performance and record the rack of previous results to support the analysis of the progress of different epidemiological measure PHE by different approaches of rapid response and preparedness framework.10 Eventually, M&E establishes and enhances the improvement of future strategic planning.11,12 Evaluation reports are designed to point out the advantages and disadvantages of a specific solution to learn new lessons crucial for updating policy.10, 11, 12 Operational research (OR) is becoming increasingly important in national and international public health treatments and programs as it aims to direct program execution for the greatest outcomes continuously.13,14 In this regard, documentation of M&E and OR can provide lessons from previous mistakes or success that is helpful in future planning for data collection and analysis. Documentation of successful M&E and OR practices can be helpful to replicate the same practice in countries and situations with similar settings during future PHE. Though, the government of the countries where an emergency arises or the international body like WHO has to take drastic and rapid action to overcome the situation. Therefore, there might not have enough time to conduct M&E or OR, due to a lack of time and technical resources.

In this review, we focus on documentation practices of M&E and OR during outbreaks in SEAR countries. We highlight issues of utmost importance, briefly discuss case examples that illustrate some of these issues, and offer suggestions on how to enhance the management of emerging infectious diseases.

Methods

This systematic review followed the methodology of Cochrane systematic reviews15 and PRISMA guidelines.16,17 This systematic review is registered in PROSPERO and the registration number is CRD 42022354118.

This review included studies that met the inclusion criteria (see Search strategy and selection criteria panel at the end). Studies were excluded based on exclusion criteria and we followed the prioritisation and sequential exclusion methods while reporting the reasons for exclusion.18 Studies retrieved from the initial search were exported into the reference management software, EndNote. After removing duplicates, all articles were screened in two phases, and finally, this review included 29 studies for extracting data. Studies were screened by title and abstract using Rayyans QCRI software (online).19 Four reviewers were involved in the screening process; two from each group independently screened studies by title and abstract and accordingly full text. The lead reviewer resolved any confusion or disagreement regarding inclusion between the reviewers.

Two review authors independently extracted data using a data extraction form that included the following criteria: author, publication year, publication type (e.g. original research), study design, country, intervention, details about interventions, the disease that causes the pandemic, duration of the pandemic, the focus of M&E, mechanism of M&E, M&E findings, the focus of OR, findings of OR, etc. At the commencement of data extraction, pilot data extraction was done with an eligible study to check the suitability of the data extraction tool. At this stage, every reviewer had extracted data from the same study to check the consistency and a similar understanding of data extraction. Any disagreement between the reviewers was resolved through discussion with the lead reviewer and an opinion was taken from the review team if necessary.

We assessed the risk of bias of the included peer-reviewed articles using the ROBANS (tool for risk of bias assessment for non-randomised studies) tool20 based on the domains of the tool, such as selection of participants, confounding variables, measurement of exposure, blinding of outcome assessments, incomplete outcome data, and selective outcome reporting. Studies were ranked as low risk of bias, high risk of bias, and unclear risk of bias depending on the reviewers’ judgments.

Data analysis

We conducted a narrative synthesis following the review objective and outcome measures. We have mapped and summarised the available evidence. A narrative synthesis was performed following three steps: (i) logical organisation of the articles by M&E and OR conducted during PHE; (ii) within-study synthesis; (iii) cross-study synthesis. Regarding cross-synthesis, we have described the studies by disease and country. However, meta-analysis was not possible due to the high heterogeneity of the data.

Stakeholder consultation

We organised two stakeholder consultation meetings. The first meeting was to finalise the methods including Population, Content, and Context (PCC) of the review. The second meeting was to validate the results of the review and to get recommendations from the stakeholders.

Results

In total, we identified and screened 22,655 potential studies by conducting a comprehensive search in selected databases. Of those, 150 papers were considered for the full-text evaluation, of which 43 articles were retrieved from agencies and ministries and one from the hand search. In the final stage of selection, 121 studies were excluded according to the selection criteria. Finally, we selected 29 articles for data extraction as they fulfilled the inclusion criteria, among which 27 were peer-reviewed articles, and two were reports. Fig. 1 presents the PRISMA flow diagram of the detailed selection process of the studies.

Fig. 1.

Fig. 1

PRISMA flow diagram. ∗M&E, Monitoring and evaluation; OR, Operational research; SEAR, southeast Asian region.

This review included studies from several SEAR countries except for Sri Lanka, Myanmar, Bhutan, and Timor-Leste. We did not find any single study conducted in South Korea, but a multi-country study presented findings from South Korea.

Characteristics of the included studies

Among the included studies, 25 studies focused on M&E21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45 and four studies on OR.46, 47, 48, 49 Most of the included studies followed a cross-sectional design, whereas two were retrospective studies29,44 and one was a cohort study.40 Most of the articles were original research published in peer-reviewed journals. Apart from those, one viewpoint,46 one field action report,47 one perspective,30 and one policy analysis36 were included, of which 20 studies were related to COVID-19.22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34,36,37,39,40,44,45 Table 1 presents the characteristics of the included studies.

Table 1.

Characteristics of included studies.

Study details
Disease outbreak Findings of M&E Findings of OR
Author, year, country Study design Article type
Ambat et al., 202221; India Cross-sectional Original research Emerging infectious diseases Gap analysis of preparedness among hospital staffs N/A
Aroskar et al., 202222; India Cross-sectional Original research COVID-19 M&E of PoEasurveillance system N/A
Biswas et al., 202023; Bangladesh Cross-sectional Original research COVID-19 Analysis of country preparedness N/A
Choudhury et al., 202224; India Cross-sectional Original research COVID-19 Compared health systems preparedness among different states N/A
Garg et al., 202046; India Cross-sectional Viewpoint COVID-19 N/A Introduced disease surveillance app–“Aarogya Setu"
Gopinathan et al., 202125; India Cross-sectional Original research COVID-19 Disaster preparedness and planning strategies among various academic EDs N/A
Gyanwali et al., 202126; Nepal Cross-sectional Original research COVID -19 Analysis of preparedness & response status among Govt. COVID-19 hospitals and clinics N/A
Hanafusa et al., 201247; Indonesia Cross-sectional Field action report Human avian influenza N/A Establishing short messaging service (SMS) gateway for pandemic reports
Huda et al., 202248; Indonesia Cross-sectional Original research COVID-19 N/A Multi-sectoral training on contact tracing
Jakariya et al., 2022,28 Bangladesh Cross-sectional Original research COVID-19 Geo-mapping of SARS-CoV-2 using wastewater samples N/A
Jiao et al., 202229; India Retrospective study Original research COVID-19 Analysis of effectiveness of containment strategies N/A
Kirubakaran et al., 202030; India Cross-sectional Perspective COVID-19 Analysis of transmission of infectious disease using a mathematical model N/A
Kundapur et al., 202232; India Cross-sectional Original research COVID-19 Comparison of bottlenecks in implementing PH initiatives among high and low health index states N/A
Kurup et al., 202133; India Cross-sectional Original article Emerging infectious diseases Performance level analysis of health workers N/A
Manurung et al., 202035; Indonesia Cross-sectional Original research Diarrhoea, malaria, dengue, bloody diarrhoea, influenza and pneumonia Evaluated usefulness of EWARSa in a remote province of Indonesia N/A
Marome et al., 202136; Thailand Cross-sectional Policy analysis COVID-19 Analysis of community-level PHa systems and governmental regulations N/A
Mukhopadhyay and Patnaik, 201449; India Cross-sectional Original research Malaria N/A Evaluated quality and coverage of Indoor Residual Spray (IRS)
Neogi et al., 202037; India Cross-sectional Original research COVID-19 Evaluate the health systems according to WHOa building blocks N/A
Nikolay et al., 202038; India Cross-sectional Original research Nipah Assessment of changes in transmission of NIVa and trend of morbidity/mortality through routine surveillance N/A
Panda et al., 202239; India Mixed-method Original research COVID-19 Evaluated skill of peripheral HCW using ECHO telemonitoring model N/A
Salvatore et al., 2020,40 India Cohort-study Original research COVID-19 Evaluation of national lockdown N/A
Sathyapalan et al., 202141; India Cross-sectional Original research Candida Auris (C. Auris) infection Assessment the incidence of C. Auris outbreak & epidemiological characteristics N/A
Troeger et al., 201442; Bangladesh Cross-sectional Original research Cholera Analysis of cost-effectiveness of using cholera vaccine N/A
Vong et al., 201643; SEAR Cross-sectional Original research Ebola Analysis of health system preparedness in the WHO- SEAR region N/A
Wang et al., 2022,44 South-Korea; India Retrospective study Original research COVID-19 Evaluated health systems according to WHO building blocks N/A
Zachariah et al., 202045; India Cross-sectional Original research COVID-19 Analysis of OR skills of HCW N/A
Shahrin et al., 202234; Bangladesh Cross-sectional Original research COVID-19 Knowledge of HCWs regarding SARS-CoV-2 infection N/A
Uematsu et al., 202027; Nepal Not mentioned Report COVID-19 Evaluated the effectiveness of handwashing program N/A
Kiss et al., 202031; Maldives Not mentioned Report COVID-19 Evaluating the implementation of ESMF in monitoring the emergency response and health systems preparedness N/A
a

ESMF: Emergency response of Environmental and Social Management Framework, EWARS: Early warning and response system; PH: Public Health; PoE: point of entry; N/A: not applicable.

Quality assessment

A risk of bias assessment was done for the 27 peer-reviewed articles. There are six domains in total, among which two domains focus on selection bias (selection of participants and confounding variables) (Fig. 2). The highest number of studies (n = 22) was assessed as a low risk of reporting bias and attrition bias, followed by the selection bias of participants.37 Most of the studies were found to have unclear risk of bias in terms of blinding of outcome assessment. There is a potential risk of detection bias within the studies as maximum studies (n = 25) were assessed as having unclear risk of bias in the blinding of outcome assessments; one study22 was evaluated as a high risk of bias, while the other34 had a low risk of bias. Regarding confounding variables, 14 studies were evaluated as having unclear risk of bias and the remaining studies were considered as low risk of bias.

Fig. 2.

Fig. 2

Risk of bias (ROB) of included studies using ROBANS tool.

M&E in response to PHE

Several PHE situations have occurred in SEAR in the last 10 years due to various types of emerging infectious diseases as the review captured (Table 2). This review captured different domains of M&E that were performed in response to the PHE.

Table 2.

Disease specific monitoring and evaluation (M&E) practices in southeast Asian region (SEAR) countries.

Focus of M&E Findings from M&E
COVID-19: M&E in India
Health systems preparedness
  • Health systems preparedness of different states and union territories and identified states with very good or poor preparedness24

  • National level coordination and planning during management32

  • Guideline of case management24

  • Countries performance of healthcare25

  • Infrastructure and equipment24

  • Governance and socio-economic measure24,29

  • Public-private partnership in the process of COVID-19 management24,32

  • Decision making power to the frontline health workers32

  • Knowledge, perception, and awareness development34

Surveillance and rapid response
  • PoE surveillance system for early detection of cases22

  • Assessed case fatality and positivity rate40

PH measures in infection, prevention, and control
  • Containment strategy—implementation of lockdown29,30,40

  • Free screening, contact tracing and treatment29

Case management
  • Separate triage system25

  • Critical case management25

  • Separate transportation and carrying pathway of COVID-19 patient25,32

  • Distribution of PPE to control the infection among health workers25

Health workforce
  • Availability of health workforce25

  • Capacity development and performance evaluation of health workforce25,32

COVID-19: M&E in Bangladesh
Coordination, planning and monitoring (country-level)
  • Health systems preparedness, national level coordination and planning during management23

Surveillance, rapid response and case investigation
  • Geo-mapping of SARS-CoV-2 using waste-water surveillance28

Health workforce
  • Capacity development and performance evaluation23

  • Knowledge, perception, and awareness development among doctors and nurses34

COVID-19: M&E in other SEAR countries (Thailand, Nepal, and Maldives)
Surveillance, rapid response, and case investigation
  • PoE surveillance system in Thailand36

  • Surveillance and rapid response in South Korea and India44

Infection, prevention, and control (IPC measure)
  • Early detection using infrared thermometer26

  • Implementation of containment strategy in Thailand36

  • Handwashing—as preventive measure in Nepal26,27

Case management
  • Separate transportation for carrying COVID-19 patients in Thailand36

Risk communication and community engagement (RCCE)
  • Promote handwashing in Nepal26

  • Community engagement and behavior change in Maldives31

Infrastructure
  • Availability and supply of infrastructure and equipment; e.g. ventilator, PPE [Nepal26; Thailand36]

Cholera and Nipah outbreak in Bangladesh
Infection, prevention, and control (IPC measure)
  • Vaccination strategy regarding cost-effectiveness and vaccination coverage of cholera vaccine42

Vector transmission
  • Transmission of emerging pathogen by describing Nipah virus spillover risk, inter-human transmission and morbidity/mortality38

Ebola in SEAR countries43
Surveillance
  • Indicator and event-based surveillance

Early detection
  • Laboratory testing capacity (molecular diagnosis)

Health workforce
  • Safety measure for health workforce

Multiple infectious diseases
Case management
  • Critical care21

Early detection
  • Lab-based screening for early detection21

Rapid response laboratory
  • Availability of laboratory and its diagnostic capacity21

Awareness
  • Awareness of lab personnel regarding referral labs inside and outside the district and reporting system21

Health workforce
  • Surveillance management training21

  • Capacity building on early detection through e-learning portal in Indonesia35

  • Capacity building of peripheral health workers in outbreak detection, investigation33

PoE surveillance: point of entry surveillance; PPE: personal protective equipment.

In total, 20 studies focused on COVID-19. Among these, the highest number of studies were conducted in India (n = 9)22,24,25,29,30,32,39,40,45 followed by the number of included studies from Bangladesh (n = 3)23,29,34 One was a multi-country study from which we included findings of South Korea and India.34 M&E conducted in Nepal was reported in two studies26,27; and one study from each of the countries of Thailand,36 Indonesia,35 and Maldives.31 In India, M&E focused on country-level health systems preparedness, surveillance and rapid response, public health (PH) measures taken for infection prevention and control (IPC measure), the process involved in case management, and availability and performance of the health workforce. On the other hand, in Bangladesh, M&E was done on country-level health systems preparedness, national-level coordination, and planning regarding the process of case management, surveillance through geo-mapping of SARS-CoV-2, capacity development of health workforce and knowledge and awareness development of doctors and nurses. Thailand, Nepal, and Maldives mostly focused on IPC measures through the point of entry (PoE) surveillance system for early detection and screening, implementation of containment strategy, and separate transportation for carrying COVID patients. Nepal, and Maldives have also taken preventive measures like handwashing and emphasized risk communication and community engagement in promoting handwashing. In addition, M&E also considered the role of infrastructure in COVID case management and found out inadequate ventilators, inadequate space for arranging separate treatment care, and a shortage of ambulances hampered the transportation of the COVID patient.

One study reported the regional preparedness of the southeast Asian region (SEAR) during the Ebola pandemic focusing on surveillance, early detection, and safety measures for the health workforce.46 Three studies discussed preparedness in India and Indonesia to battle PHE due to any emerging infectious diseases where capacity building in early detection was prioritised.21,33,35

OR practices in response to PHE

We have a total of four studies that reported OR conducted in two countries. To battle COVID-19, two studies related to OR were carried out but with different focuses, one in Indonesia48 and another one in India.46 In India, a disease surveillance mobile application, ‘Aarogya Setu’ was introduced to strengthen the existing participatory disease surveillance system46 whereas, Indonesia emphasised enhancing the capacity of health staff for early warning.48 In this regard, the training program involved the Ministry of Health, the COVID-19 National Task Force, the Ministry of Education and Culture, universities, and international partners all collaborated to host a series of contact tracing training programs across Indonesia. In addition to primary healthcare providers, community volunteers, young professionals, and college students were trained to enable them in conducting COVID-19 contact tracing and managing data across Indonesia. Two other studies that were conducted in India49 and Indonesia47 focused on malaria and human avian influenza respectively. In Indonesia, they focused on the short messaging service (SMS) gateway to handle human avian influenza, while in India they focused on the indoor residual spray (IRS) program to manage malaria.

Discussion

This systematic review has identified and documented M&E practices and OR conducted during several infectious diseases-related PHE that occurred in SEAR in the last ten years. The present systematic review underpins 29 studies (27 peer-reviewed articles and two reports) assessing preparedness, surveillance systems, infection prevention and control, health workforce, health systems, public health measures undertaken, and capacity building towards M&E and OR management in SEAR countries. Among the 29 studies, 25 studies focused on M&E, and four studies were on OR. The highest number of studies which focused on M&E came from India followed by the number of studies from Bangladesh. During the last 10 years, the most highlighted PHE situation occurred due to COVID-19.

Studies on M&E ensure accountability of programs and interventions, and efficient use of resources as planned.21,23,24 Different research focused on identifying areas of improvement and proposed course corrections and adaptations to ensure an effective and relevant program.29,32,33,35 Evidence-based decision-making was targeted by generating data using program scaling-up and testing alternative approaches.26,35,36,42 Research facilitated learning by identifying valid methods of interventions and clarifying the scope of improvements.31,39, 40, 41 Impact assessment was generated by assessing the impact of programs and interventions on intended outcomes, including changes in behaviour, knowledge, and attitudes.31,34,44,45

Despite the heterogeneity of data for countries and diseases, most research focused on the national level of preparedness against infectious disease-related PHE. Different tiers of preparedness were reported by assessing the preparedness of district-level private hospitals,21 preparedness of academic emergency departments,25 and preparedness of government-designated COVID-19 hospitals and clinics.26 Another study documented M&E conducted in SEAR countries focusing on regional preparedness during Ebola.43 Preparedness in terms of infrastructure (bed capacity, separate space for isolation or quarantine, separate systems for transportation and treatment of infected patients), laboratory facilities for rapid response, facility for critical care and availability of human resources for health were assessed where either adequacy or gaps in preparedness were reported. On the other hand, the major weakness reported through research on preparedness was the lack of adequate infrastructure and technical expertise.43 During the Ebola Virus Disease (EVD) outbreak in 2014 in Nigeria, preparedness was explored by identifying gaps and developing relevant protocol.50

Risk communication is another critical component for M&E which is necessary for the improvement of communication strategies through the four studies.23,31,43,44 Strengths and weakness in developing a risk communication strategy and action plan was identified in SEAR countries. In this regard, the media played an important role in promoting preventive measures like handwashing among community people. A simplified government approach was implemented by the risk communication model during COVID-19 in Wuhan province in China.51 Unfortunately, this review did not find any studies that concentered on risk communication during public health emergencies.

Surveillance is considered an application of M&E by tracking and monitoring disease trends which were elaborated by vector transmission pathways and geo-mapping of pathogens are mentionable.28,29,38,43,44 A surveillance program was also implemented in an upper-middle-income country during the COVID-19 pandemic to safeguard the health of the health workforce.52 According to our review, regarding the management of critical care, patients have faced challenges due to the inadequacy of infrastructure (e.g. lack of space, bed capacity, etc.) and availability of skilled human resources.23,25,36 Similar challenges were also identified in the WHO-Eastern Mediterranean Region.53 Another review study also reported the role of infrastructure in critical care in the most affected countries due to COVID-19.54

This review reported an early warning system through the implementation of SMS to facilitate the early detection of persons potentially exposed to infectious diseases like COVID-19, and Ebola in SEAR countries. The EU has already successfully implemented this approach in Nigeria and Senegal, where Ebola was being monitored for signs and symptoms.55

Our study findings were mostly aligned with the M&E indicators identified by the WHO.10 In addition, this review reported the availability of a health workforce and the need for capacity-building training in India, Bangladesh, Nepal, and Indonesia. The health workforce faced a heavy workload during COVID-19.23, 24, 25, 26,32,33,35,45 Besides, several previous studies reported challenges regarding the number and performance of health staff.56, 57, 58, 59 Several studies have indicated an insufficient supply of personal protective equipment (PPE) and its poor quality triggers the possibility of infection. This review captured no evidence of M&E focusing on essential medical services during the pandemic. The COVID-19 epidemic is posing a tremendous challenge to healthcare systems all around the world. An Ethiopian study reported that during the pandemic, the health care service was dramatically reduced for family planning (98%), emergency surgery (77%), and follow-up of chronic surgical conditions (70%).60 Another study found in Mexico stated that according to the analysis, Mexico lost an estimated 8.74 million patient visits across nine health services.61

Our review has documented several practices of M&E in SEAR countries during PHE in the last ten years. Though the domains of M&E identified in the included studies are aligned with WHO M&E indicators, no unique form of M&E was reported. In response to a similar type of PHE due to a similar disease, different countries and, in some cases, the same country performed M&E with a different focus. Therefore, we need to find out what type of initiative is appropriate to fight different types of diseases. Even a specific combination of actions was not possible to identify. Considering this issue, a standard framework of M&E for SEAR countries needs to be developed to conduct M&E during PHE.

Out of 25 studies focusing on M&E practices, 18 studies reported PHE due to COVID-19. Other than COVID-19, the rest of the studies documented M&E practice during cholera, Nipah, Ebola, and Candida auris infection, and another study focused on PHE due to multiple infectious diseases. Other than COVID-19, there were several outbreaks in this region several times such as swine flu, influenza, dengue, diarrhoea, and monkeypox.62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73 Unfortunately, the review was unable to explore the evidence of M&E practice during PHE due to those diseases mentioned despite using a comprehensive search strategy. Similarly, most of the evidence of M&E practice came from India followed by Bangladesh. Moreover, evidence from Bhutan, Sri Lanka, Myanmar, and Timor-Leste was absent. These findings indicate the need for documentation of M&E practice in those countries.

In the SEAR, OR practice during PHE is limited (only four studies). But one review study showed that OR could contribute to healthcare operations by analysing staff scheduling, medicine and vaccine allocation, logistics, and solving decision-making problems.74 A study conducted in the Eastern Mediterranean Region reported that PHE operation centres (OCs) are a good way to handle situations like this. Many nations have demonstrated success in developing effective response mechanisms for various kinds of hazards.75 Our review study observed that operational research on disease outbreaks or other PHE could be more robust in SEAR.

This review evidenced OR practices only in India and Indonesia during PHE in the last decade. Here, the reported PHE has occurred in India due to COVID-19 and malaria and in Indonesia due to COVID-19 and influenza. Despite the prevalence of several pandemics or outbreaks across other SEAR countries OR practices were reported as very limited in comparison to the M&E practices. Considering this situation, extensive OR practices could contribute to the government's effort in each country to overcome the PHE situation and help them in developing effective strategies to fight the situation.

The objective of our systematic review was to explore the documentation practice of M&E and OR during PHE within the last decade. We identified studies where evidence regarding M&E practices in India and Bangladesh was prominent. Moreover, the review captured evidence about OR practices from only two countries—India and Indonesia. Other SEAR countries might have practiced several M&E and OR programs that they were unable to document and publish. Therefore, despite using a comprehensive search strategy the review could not identify the unpublished works. During our stakeholder consultation, in response to PHE, we received some suggestions and country-specific guidelines for conducting M&E and OR. In addition to this, they emphasised on to develop specific recommendations or a framework for each country to be implemented during any pandemic or outbreak.

The main strength of this systematic review is its robust methodology. We have developed a comprehensive search strategy and considered both peer-reviewed and grey literature. In addition, we have checked the cross-references of the included studies. However, this study has few limitations. This review considered studies published only in English. Moreover, the search strategy combined with different keywords and a specific time duration limited the search results. In terms of PHE, this review considered only infectious diseases. However, it was difficult to identify any single component to be monitored and evaluated necessary to fight against any disease, as most of the M&E program emphasised multiple domains of action against PHE. Furthermore, meta-analysis was not performed due to the high heterogeneity.

Contributors

LS and KMSUR had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. LS and KMSUR had contribution of study concept and design. IN, SA, MZR and MAH contributed to the acquisition of data. IN and SA analysed and interpreted the data. IN and SA did the narrative synthesis with guidance from KMSUR. LS, IN, and SA drafted the manuscript with critical revision for important intellectual content from all authors. KMSUR provided critical input on methods, supervised the review process, and revised the manuscript.

Data sharing statement

The data used in this study can be obtained from the corresponding author upon reasonable request.

Editor note

The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations.

Declaration of interests

LS received grant (on behalf of icddr,b) from WHO SEARO for this project (grant number GR02263). The study's funder had no role in the study design, data collection, data analysis, data interpretation, or writing report. Authors declare no other conflicts of interest.

Acknowledgements

The development of the summary report of this review was coordinated by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). We would like to express our thanks and acknowledge the support of Dr. Partha Pratim Mandal, Health Emergency Officer at SEARO. We would also like express our thanks to Dr. Shahed Hossain, Dr. Mohammad Mushtuq Husain, Dr. Khaleda Islam, Dr. Iqbal Anwar and Dr. Praveen Devarsetty for their valuable suggestions and inputs to develop the summary report. We acknowledge the WHO-SEARO for their close collaboration that made the systematic review possible within a tight timeline and with limited financial resources. Recognition is given to the authors of materials that were included in the above systematic reviews. We express our gratitude to the WHO-SEARO for the financial support that made this work possible. We are also grateful to the Governments of Bangladesh, Canada, Sweden and the UK aid for providing core and unrestricted support to icddr,b.

Footnotes

Appendix A

Supplementary data related to this article can be found at https://doi.org/10.1016/j.lansea.2023.100340.

Appendix A. Supplementary data

Supplementary Figure S1 and Supplementary Tables S1–S6
mmc1.docx (64.4KB, docx)

References

  • 1.Coker R.J., Hunter B.M., Rudge J.W., Liverani M., Hanvoravongchai P. Emerging infectious diseases in southeast Asia: regional challenges to control. Lancet. 2011;377(9765):599–609. doi: 10.1016/S0140-6736(10)62004-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Organization WH . World Health Organization; 2008. The global burden of disease: 2004 update. [Google Scholar]
  • 3.Jones K.E., Patel N.G., Levy M.A., et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–993. doi: 10.1038/nature06536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Woolhouse M.E., Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis. 2005;11(12):1842. doi: 10.3201/eid1112.050997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Patz J.A., Daszak P., Tabor G.M., et al. Unhealthy landscapes: policy recommendations on land use change and infectious disease emergence. Environ Health Perspect. 2004;112(10):1092–1098. doi: 10.1289/ehp.6877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Asia TLRHS . Elsevier; 2022. New vision for a healthier southeast Asia. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Arinaminpathy N., Sinha A., Anvikar A.R., et al. CDDEP; 2021. "Infectious diseases in the South-East Asia Region". [Google Scholar]
  • 8.Nelson C., Lurie N., Wasserman J., Zakowski S. Conceptualizing and defining public health emergency preparedness. Am J Public Health. 2007:S9–S11. doi: 10.2105/AJPH.2007.114496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Craig A., Kasai T., Li A., Otsu S., Khut Q. Getting back to basics during a public health emergency: a framework to prepare and respond to infectious disease public health emergencies. Publ Health. 2010;124(1):10–13. doi: 10.1016/j.puhe.2009.11.011. [DOI] [PubMed] [Google Scholar]
  • 10.World Health Organization . 2020. COVID-19 strategic preparedness and response (SPRP): monitoring and evaluation framework. [Google Scholar]
  • 11.Joint Commission Resources, Inc . Joint Commission Resources; 2012. Emergency management in health care: an all-hazards approach. [Google Scholar]
  • 12.Gossip K., Gouda H., Lee Y.Y., et al. Monitoring and evaluation of disaster response efforts undertaken by local health departments: a rapid realist review. BMC Health Serv Res. 2017;17(1):1–11. doi: 10.1186/s12913-017-2396-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.der Heide E.A. The importance of evidence-based disaster planning. Ann Emerg Med. 2006;47(1):34–49. doi: 10.1016/j.annemergmed.2005.05.009. [DOI] [PubMed] [Google Scholar]
  • 14.Malhotra S., Zodpey S.P. Operations research in public health. Indian J Publ Health. 2010;54(3):145. doi: 10.4103/0019-557X.75737. [DOI] [PubMed] [Google Scholar]
  • 15.Higgins J. 2011. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0.www.cochrane-handbook.org [updated March 2011]. The Cochrane Collaboration. [Google Scholar]
  • 16.Moher D., Shamseer L., Clarke M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9. doi: 10.1186/2046-4053-4-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Saif-Ur-Rahman K.M., Hasan M., Hossain S., Anwar I., Hirakawa Y., Yatsuya H. Prioritization and sequential exclusion of articles in systematic reviews. Campbell Syst Rev. 2022;18(2):e1229. doi: 10.1002/cl2.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10. doi: 10.1186/s13643-016-0384-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kim S.Y., Park J.E., Lee Y.J., et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408–414. doi: 10.1016/j.jclinepi.2012.09.016. [DOI] [PubMed] [Google Scholar]
  • 21.Ambat A.S., Vyas N. Assessment of preparedness against emerging infectious disease among private hospitals in a district of South India. Med J Armed Forces India. 2022;78(1):42–46. doi: 10.1016/j.mjafi.2020.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Aroskar K., Sahu R., Choudhary S., Pasi A.R., Gaikwad P., Dikid T. Evaluation of point of entry surveillance for COVID-19 at Mumbai international airport, India, July 2020. Indian J Public Health. 2022;66(1):67–70. doi: 10.4103/ijph.ijph_1487_21. [DOI] [PubMed] [Google Scholar]
  • 23.Biswas R.K., Huq S., Afiaz A., Khan H.T.A. A systematic assessment on COVID-19 preparedness and transition strategy in Bangladesh. J Eval Clin Pract. 2020;26(6):1599–1611. doi: 10.1111/jep.13467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Choudhury S., Majumdar A., Saha A.K., Majumdar P. Evaluating the preparedness of Indian States against COVID-19 pandemic risk: a Fuzzy multi-criteria decision-making approach. Risk Anal. 2022;42(1):85–96. doi: 10.1111/risa.13808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gopinathan V., Asanar S., Krishnan S.V., Sirur F.M., Balakrishnan J.M. Assessment of the preparedness and planning of academic emergency departments in India during the COVID-19 pandemic–a multicentric Survey. Disaster Med Public Health Prep. 2021;16:1–13. doi: 10.1017/dmp.2021.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gyanwali P., Bista N.R., Khadka M., et al. Assessment of preparedness of government of Nepal in COVID designated hospitals and clinics for pandemic response. J Nepal Health Res Counc. 2021;19(1):48–54. doi: 10.33314/jnhrc.v19i1.3237. [DOI] [PubMed] [Google Scholar]
  • 27.Uematsu H., Joshi S., Maharjan L. 2020. Beyond raising awareness: promoting handwashing in Nepal amid COVID 19 crisis. [Google Scholar]
  • 28.Jakariya M., Ahmed F., Islam M.A., et al. Wastewater-based epidemiological surveillance to monitor the prevalence of SARS-CoV-2 in developing countries with onsite sanitation facilities. Environ Pollut. 2022;311 doi: 10.1016/j.envpol.2022.119679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Jiao J., Shi L., Chen H., et al. Containment strategy during the COVID-19 pandemic among three Asian low and middle-income countries. J Glob Health. 2022;12 doi: 10.7189/jogh.12.05016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kirubakaran S., Ramraj B. Assessing the effect of lockdown on COVID-19 pandemic through risk prediction model in major cities of India. Int J Health Allied Sci. 2020;9:68–72. doi: 10.4103/ijhas.IJHAS_103_20. [DOI] [Google Scholar]
  • 31.Kiss A.I. 2020. Environmental and social management framework (ESMF) Maldives COVID-19 emergency Response and health systems preparedness project. [Google Scholar]
  • 32.Kundapur R., Rashmi A., Velamala S., et al. Assessment of challenges and opportunities and Identification of approaches and Innovations in COVID-19 pandemic management by different States in India: a qualitative approach. J Epidemiol Glob Health. 2022;12(1):74–84. doi: 10.1007/s44197-021-00022-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kurup K.K., Manickam P., Prakash M. Evaluation through outbreak simulation exercise points to the need for considerable improvement in the capacity of peripheral health workers for outbreak detection and response, South India, 2018. J Fam Med Prim Care. 2021;10(4):1587–1591. doi: 10.4103/jfmpc.jfmpc_1702_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Shahrin L., Sarmin M., Abbassi N.A., et al. In-person training on COVID-19 case management and infection prevention and control: evaluation of healthcare professionals in Bangladesh. PLoS One. 2022;17(10) doi: 10.1371/journal.pone.0273809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Manurung M.K., Reo S.E., Pardosi J.F., Muscatello D.J. Evaluation of the Indonesian early warning Alert and response system (EWARS) in west Papua, Indonesia. WHO South East Asia J Public Health. 2020;9(2):111–117. doi: 10.4103/2224-3151.294304. [DOI] [PubMed] [Google Scholar]
  • 36.Marome W., Shaw R. COVID-19 response in Thailand and its implications on future preparedness. Int J Environ Res Publ Health. 2021;18(3):1–11. doi: 10.3390/ijerph18031089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Neogi S.B., Preetha G.S. Assessing health systems' responsiveness in tackling COVID-19 pandemic. Indian J Public Health. 2020;64:S211–S216. doi: 10.4103/ijph.IJPH_471_20. [DOI] [PubMed] [Google Scholar]
  • 38.Nikolay B., Salje H., Khan A.K.M.D., et al. A framework to monitor changes in transmission and epidemiology of emerging pathogens: lessons from nipah virus. J Infect Dis. 2020;221:S363–S369. doi: 10.1093/infdis/jiaa074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Panda R., Mishra N., Lahoti S., et al. Evaluation of COVID-19 ECHO training program for healthcare workers in India–a Mixed-Method Study. BMC Health Serv Res. 2022;22(1) doi: 10.1186/s12913-022-08288-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Salvatore M., Basu D., Ray D., et al. Comprehensive public health evaluation of lockdown as a non-pharmaceutical intervention on COVID-19 spread in India: National trends masking state-level variations. BMJ Open. 2020;10(12) doi: 10.1136/bmjopen-2020-041778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sathyapalan D.T., Antony R., Nampoothiri V., et al. Evaluating the measures taken to contain a Candida auris outbreak in a tertiary care hospital in South India: an outbreak investigational study. BMC Infect Dis. 2021;21(1) doi: 10.1186/s12879-021-06131-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Troeger C., Sack D.A., Chao D.L. Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator. Am J Trop Med Hyg. 2014;91(6):1181–1189. doi: 10.4269/ajtmh.14-0159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Vong S., Samuel R., Gould P., et al. Assessment of Ebola virus disease preparedness in the WHO South-East asia region. Bull World Health Organ. 2016;94(12):913–924. doi: 10.2471/BLT.16.174441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wang X., Shi L., Zhang Y., et al. A comparative retrospective study of COVID-19 responses in four representative Asian countries. Risk Manag Healthc Pol. 2022;15:13–25. doi: 10.2147/RMHP.S334326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zachariah R., Berger S.D., Thekkur P., et al. Investing in operational research capacity building for front-line health workers strengthens countries' resilience to tackling the COVID-19 pandemic. Trop Med Infect Dis. 2020;5(3) doi: 10.3390/tropicalmed5030118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Garg S., Bhatnagar N., Gangadharan N. A case for participatory disease surveillance of the COVID-19 pandemic in India. JMIR Public Health Surveill. 2020;6(2):221–225. doi: 10.2196/18795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hanafusa S., Muhadir A., Santoso H., et al. A surveillance model for human avian influenza with a comprehensive surveillance system for local-priority communicable diseases in South Sulawesi, Indonesia. Trop Med Health. 2012;40(4):141–147. doi: 10.2149/tmh.2012-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Huda N., Utami A., Mayadewi C., et al. Accelerating COVID-19 contact tracing capacity through multi-Sectoral collaboration training in Indonesia. Int J Infect Dis. 2022;116:S32. doi: 10.1016/j.ijid.2021.12.076. (abstr) [DOI] [Google Scholar]
  • 49.Mukhopadhyay A.K., Patnaik S.K. Evaluation of ongoing indoor residual spray programme in some malaria endemic districts of Andhra Pradesh, India. IIndian J Public Health. 2014;5(1):101–104. [Google Scholar]
  • 50.Olumade T.J., Adesanya O.A., Fred-Akintunwa I.J., et al. Infectious disease outbreak preparedness and response in Nigeria: history, limitations and recommendations for global health policy and practice. AIMS Public Health. 2020;7(4):736. doi: 10.3934/publichealth.2020057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zhang L., Li H., Chen K. Effective risk communication for public health emergency: reflection on the COVID-19 (2019-nCoV) outbreak in Wuhan, China. Healthcare. 2020 doi: 10.3390/healthcare8010064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wan K.S., Tok P.S.K., Yoga Ratnam K.K., et al. Implementation of a COVID-19 surveillance programme for healthcare workers in a teaching hospital in an upper-middle-income country. PLoS One. 2021;16(4) doi: 10.1371/journal.pone.0268492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kodama C., Kuniyoshi G., Abubakar A. Lessons learned during COVID-19: building critical care/ICU capacity for resource limited countries with complex emergencies in the World Health Organization Eastern Mediterranean Region. J Glob Health. 2021;11 doi: 10.7189/jogh.11.03088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Patra E.S.K., Mishra S.B., Mallisha S., Mohanty J.N. Role of health care infrastructure and expenditure on COVID19 pandemic: scenario from most affected countries. Natl J Community Med. 2022;13(2):120–125. [Google Scholar]
  • 55.Tracey L., Regan A., Armstrong P., Dowse G., Effler P. EbolaTracks: an automated SMS system for monitoring persons potentially exposed to Ebola virus disease. Euro Surveill. 2015;20(1) doi: 10.2807/1560-7917.es2015.20.1.20999. [DOI] [PubMed] [Google Scholar]
  • 56.Poon Y.-S.R., Lin Y.P., Griffiths P., Yong K.K., Seah B., Liaw S.Y. A global overview of healthcare workers' turnover intention amid COVID-19 pandemic: a systematic review with future directions. Hum Resour Health. 2022;20(1):1–18. doi: 10.1186/s12960-022-00764-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Hassan M.Z., Monjur M.R., Styczynski A.R., Rahman M., Banu S. Protecting frontline healthcare workers should be the top priority in low-resource health systems: Bangladesh and COVID-19. Infect Control Hosp Epidemiol. 2021;42(1):121–122. doi: 10.1017/ice.2020.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Pooja S.D., Nandonik A.J., Ahmed T., Kabir Z.N. “Working in the dark”: experiences of frontline health workers in Bangladesh during COVID-19 pandemic. J Multidiscip Healthc. 2022;15:869. doi: 10.2147/JMDH.S357815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Roy S., Kennedy S., Hossain S., Warren C.E., Sripad P. Examining roles, support, and experiences of community health workers during the COVID-19 pandemic in Bangladesh: a mixed methods study. Glob Health Sci Pract. 2022;10(4) doi: 10.9745/GHSP-D-21-00761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Abdela S.G., Berhanu A.B., Ferede L.M., van Griensven J. Essential healthcare services in the face of COVID-19 prevention: experiences from a referral hospital in Ethiopia. Am J Trop Med Hyg. 2020 Sep;103(3):1198. doi: 10.4269/ajtmh.20-0464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Doubova S.V., Robledo-Aburto Z.A., Duque-Molina C., et al. Overcoming disruptions in essential health services during the COVID-19 pandemic in Mexico. BMJ Glob Health. 2022;7(3) doi: 10.1136/bmjgh-2021-008099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Chatterjee P. Nipah virus outbreak in India. Lancet. 2018;391(10136):2200. doi: 10.1016/S0140-6736(18)31252-2. [DOI] [PubMed] [Google Scholar]
  • 63.Hsu V.P., Hossain M.J., Parashar U.D., et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis. 2004;10(12):2082. doi: 10.3201/eid1012.040701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Singh M., Sharma S. An epidemiological study of recent outbreak of influenza A H1N1 (swine flu) in Western Rajasthan region of India. J Med Allied Sci. 2013;3(2):48. [Google Scholar]
  • 65.Rafi A., Mousumi A.N., Ahmed R., Chowdhury R.H., Wadood A., Hossain G. Dengue epidemic in a non-endemic zone of Bangladesh: clinical and laboratory profiles of patients. PLoS Neglected Trop Dis. 2020;14(10) doi: 10.1371/journal.pntd.0008567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Khatri G., Mir S.L., Hasan M.M. Outbreak of monkeypox in south East Asia; spotlight on Bangladesh, Pakistan and India. Ann Med Surg. 2022;82 doi: 10.1016/j.amsu.2022.104361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Anwar S., Taslem Mourosi J., Khan M.F., Ullah M.O., Vanakker O.M., Hosen M.J. Chikungunya outbreak in Bangladesh (2017): clinical and hematological findings. PLoS Neglected Trop Dis. 2020;14(2) doi: 10.1371/journal.pntd.0007466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Mavalankar D., Shastri P., Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis. 2007;7(5):306–307. doi: 10.1016/S1473-3099(07)70091-9. [DOI] [PubMed] [Google Scholar]
  • 69.Tissera H.A., Jayamanne B.D., Raut R., et al. Severe dengue epidemic, Sri Lanka, 2017. Emerg Infect Dis. 2020;26(4):682. doi: 10.3201/eid2604.190435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Chatterjee P., Seth B., Biswas T. Hotspots of H1N1 influenza in India: analysis of reported cases and deaths (2010–2017) Trop Doct. 2020;50(2):166–169. doi: 10.1177/0049475519879357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Ramamurthy T., Sharma N.C. Cholera outbreaks in India. Curr Top Microbiol Immunol. 2014:49–85. doi: 10.1007/82_2014_368. [DOI] [PubMed] [Google Scholar]
  • 72.Khongwichit S., Chansaenroj J., Thongmee T., et al. Large-scale outbreak of Chikungunya virus infection in Thailand, 2018–2019. PLoS One. 2021;16(3) doi: 10.1371/journal.pone.0247314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Adhikari N., Subedi D. The alarming outbreaks of dengue in Nepal. Trop Med Health. 2020;48(1):1–3. doi: 10.1186/s41182-020-0194-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Choi T.M. Fighting against COVID-19: what operations research can help and the sense-and-respond framework. Ann Oper Res. 2021:1–7. doi: 10.1007/s10479-021-03973-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Elmahal O.M., Abdullah A., Elzalabany M.K., Anan H.H., Samhouri D., Brennan R.J. Public health emergency operation centres: status, gaps and areas for improvement in the Eastern Mediterranean Region. BMJ Glob Health. 2022;7(Suppl 4) doi: 10.1136/bmjgh-2022-008573. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figure S1 and Supplementary Tables S1–S6
mmc1.docx (64.4KB, docx)

Articles from The Lancet Regional Health - Southeast Asia are provided here courtesy of Elsevier

RESOURCES